このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

<string>乳房手術における術前の睡眠の質と術後転帰</string>

2026年11月16日 更新者:Mustafa Kemal ŞAHİN、Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

Association of Preoperative Sleep Quality With 24-Hour Systemic Immune-Inflammation Index, Early PACU Pain, and Analgesic Use After Breast Cancer Surgery

This prospective, single-center observational study examined the association between preoperative sleep quality and postoperative outcomes in women undergoing elective breast cancer surgery. Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI), with scores ≤5 indicating good sleep quality and scores >5 indicating poor sleep quality.

The primary outcome was the systemic immune-inflammation index (SII), calculated from routine blood counts obtained 24 hours after surgery. Postoperative SII was compared between sleep-quality groups, accounting for preoperative SII and relevant clinical and surgical characteristics. Secondary outcomes included change in SII from baseline, pain intensity during the first 45 minutes in the post-anesthesia care unit (PACU), opioid consumption, rescue analgesic requirement, and length of hospital stay. Pain was assessed using a 10-cm visual analogue scale on PACU arrival and at 15, 30, and 45 minutes. Opioid consumption included morphine and tramadol administered during the final 20 minutes of surgery and the first 45 minutes in the PACU, expressed as intravenous morphine equivalents.

No treatment was assigned by the study protocol. Anesthetic and analgesic management followed routine clinical practice.

調査の概要

状態

完了

条件

介入・治療

詳細な説明

This prospective observational study was conducted at Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital in Ankara, Turkey, among women undergoing elective breast cancer surgery under general anesthesia. Procedures included lumpectomy or mastectomy, with axillary dissection when clinically indicated. The study examined whether preoperative sleep quality was associated with postoperative systemic immune-inflammation index (SII), immediate postoperative pain, and analgesic use.

Preoperative sleep quality was assessed using the validated Turkish version of the Pittsburgh Sleep Quality Index (PSQI). The total score ranges from 0 to 21, with higher scores indicating poorer sleep quality. Patients were classified as having good sleep quality (PSQI ≤5) or poor sleep quality (PSQI >5). Demographic characteristics, comorbidities, oncological history, surgical characteristics, and perioperative clinical data were recorded prospectively.

The primary outcome was SII measured 24 hours (±6 hours) after surgery, calculated as platelet count × neutrophil count / lymphocyte count. Preoperative SII was calculated using the same formula. The primary analysis compared postoperative SII between sleep-quality groups, adjusting for baseline SII and clinical and surgical covariates. Change in SII, calculated as postoperative minus preoperative SII, was a secondary outcome.

Pain intensity was assessed using a 10-cm visual analogue scale (VAS), anchored at "no pain" and "worst imaginable pain." Patients marked their pain intensity on the line; the distance from the zero anchor was measured and rounded to the nearest whole centimeter. Assessments were performed on arrival in the post-anesthesia care unit (PACU) and at 15, 30, and 45 minutes. Maximum VAS was defined as the highest score across the four scheduled assessments. The pain assessor was unaware of patients' PSQI scores and sleep-quality groups.

Anesthetic and analgesic management followed routine clinical practice, with no treatment assigned by the study protocol. Intravenous morphine or tramadol was administered for postoperative analgesia during the final 20 minutes of surgery. Rescue analgesia consisted of intravenous morphine or tramadol when the PACU VAS score was ≥4; drug selection and dosing were determined by the treating anesthesiologist. Scheduled pain assessments continued after rescue treatment. No regional blocks or surgical local anesthetic infiltration were performed.

Total opioid consumption comprised morphine and tramadol administered during the final 20 minutes of surgery and the first 45 minutes in the PACU. Intravenous tramadol doses were converted to intravenous morphine equivalents using a factor of 0.1 and added to the administered morphine dose. Fentanyl used for induction and remifentanil used for maintenance were excluded from this measure. Rescue analgesic requirement was defined as receipt of at least one rescue opioid dose during the PACU observation period. The planned 24-hour pain and opioid outcomes could not be reliably evaluated because of follow-up limitations and incomplete opioid documentation. The reported analyses were therefore restricted to PACU pain during the first 45 minutes and opioid administration during the final 20 minutes of surgery and this PACU period. Length of hospital stay was also recorded.

Secondary analyses evaluated PSQI total score as a continuous predictor of postoperative SII, maximum VAS, total opioid consumption, and rescue analgesic requirement. Adjustment variables included age, body mass index, ASA physical status III, chronic disease burden, chemotherapy within the previous year, axillary dissection, and operation duration. Breast surgery type was added to the models during manuscript revision. Preoperative SII was included only in the postoperative SII models. Individual covariate-outcome associations were interpreted as exploratory.

研究の種類

観察的

入学 (実際)

156

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

      • Ankara、トルコ(Türkiye)、06200
        • Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital Clinic of Anesthesiology and Reanimation

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年~75年 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

女性

サンプリング方法

非確率サンプル

調査対象母集団

The study population included women aged 18-75 years who underwent elective breast cancer surgery at a tertiary oncology center. Procedures included breast-conserving surgery (lumpectomy) or mastectomy, with or without axillary dissection. Preoperative sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI). All patients received routine perioperative care, and no treatment was assigned by the study protocol. This observational study examined the association between preoperative sleep quality and postoperative outcomes in routine clinical practice.

説明

Inclusion Criteria:

  • Female patients aged 18 to 75 years
  • Scheduled for elective breast cancer surgery
  • American Society of Anesthesiologists (ASA) physical status I to III
  • Able to understand and complete the Pittsburgh Sleep Quality Index (PSQI)
  • Willing to participate in the study
  • Provided written informed consent

Exclusion Criteria:

  • Active infection
  • History of chronic inflammatory disease or autoimmune disease
  • Use of steroids or immunosuppressive drugs within the past 6 months
  • Known diagnosis of obstructive sleep apnea syndrome
  • Severe cognitive impairment preventing completion of the questionnaire
  • Planned emergency surgery
  • Refusal to participate or failure to provide informed consent

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 観測モデル:COHORT
  • 時間の展望:PROSPECTIVE

コホートと介入

グループ/コホート
介入・治療
Good Sleep Quality (PSQI ≤ 5)

Patients with good preoperative sleep quality, defined as a Pittsburgh Sleep Quality Index (PSQI) score ≤5, were included in this cohort. Sleep quality was assessed preoperatively using the validated PSQI questionnaire. No treatment was assigned by the study protocol, and patients received routine perioperative care. Postoperative SII, pain intensity, and analgesic consumption were compared with those in the poor-sleep-quality group.

Preoperative sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI), a validated self-reported questionnaire covering the preceding month. Patients were classified into two cohorts: good sleep quality (PSQI ≤5) and poor sleep quality (PSQI >5). The PSQI assessment was used for grouping and analysis. No treatment was assigned by the study protocol, and perioperative management followed routine clinical practice.

他の名前:
  • ピッツバーグ睡眠の質指数 (PSQI)
Poor Sleep Quality (PSQI > 5)

Patients with poor preoperative sleep quality, defined as a Pittsburgh Sleep Quality Index (PSQI) score >5, were included in this cohort. Sleep quality was assessed preoperatively using the validated PSQI questionnaire. No treatment was assigned by the study protocol, and patients received routine perioperative care. Postoperative SII, pain intensity, and analgesic consumption were compared with those in the good-sleep-quality group.

Preoperative sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI), a validated self-reported questionnaire covering the preceding month. Patients were classified into two cohorts: good sleep quality (PSQI ≤5) and poor sleep quality (PSQI >5). The PSQI assessment was used for grouping and analysis. No treatment was assigned by the study protocol, and perioperative management followed routine clinical practice.

他の名前:
  • ピッツバーグ睡眠の質指数 (PSQI)

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Postoperative Systemic Immune-Inflammation Index (SII)
時間枠:At 24 hours postoperatively (± 6 hours)

The primary outcome was the postoperative systemic immune-inflammation index (SII), calculated from routine complete blood count measurements obtained 24 hours after surgery. SII was calculated using the formula: platelet count × neutrophil count / lymphocyte count. Postoperative SII was compared between patients with poor (PSQI >5) and good (PSQI ≤5) preoperative sleep quality, adjusting for preoperative SII and clinical and surgical covariates.

At 24 hours postoperatively (± 6 hours)

二次結果の測定

結果測定
メジャーの説明
時間枠
Change in Systemic Immune-Inflammation Index (ΔSII)
時間枠:From the preoperative assessment to 24 hours after surgery.

Change in SII was calculated as postoperative SII minus preoperative SII. SII was calculated at both time points as platelet count × neutrophil count / lymphocyte count. Changes were compared between patients with good (PSQI ≤5) and poor (PSQI >5) preoperative sleep quality.

From the preoperative assessment to 24 hours after surgery.
Immediate Postoperative Pain Intensity
時間枠:On arrival in the post-anesthesia care unit (0 minutes) and at 15, 30, and 45 minutes after arrival.

Pain intensity was assessed using a 10-cm visual analogue scale (VAS), anchored at 0 cm ("no pain") and 10 cm ("worst imaginable pain"). Patients marked their pain intensity on the line, and the measured distance was rounded to the nearest whole centimeter. Scores were recorded at each scheduled assessment, including after rescue analgesia when applicable. Maximum VAS was defined as the highest score across the four assessments

On arrival in the post-anesthesia care unit (0 minutes) and at 15, 30, and 45 minutes after arrival.
Total Opioid Consumption for Postoperative Analgesia
時間枠:From 20 minutes before the end of surgery through the first 45 minutes after PACU arrival.

Total opioid consumption was calculated as the sum of intravenous morphine and tramadol administered for postoperative analgesia during the final 20 minutes of surgery and the first 45 minutes in the post-anesthesia care unit (PACU), including rescue doses. Tramadol doses were multiplied by 0.1 to obtain intravenous morphine equivalents and added to the morphine dose. Consumption was expressed in milligrams of intravenous morphine equivalents. Fentanyl administered during induction and remifentanil used for maintenance were excluded.

From 20 minutes before the end of surgery through the first 45 minutes after PACU arrival.
Rescue Analgesic Requirement
時間枠:Within the first 45 minutes after arrival in the post-anesthesia care unit.

Rescue analgesic requirement was defined as receipt of at least one intravenous dose of morphine or tramadol during the first 45 minutes in the post-anesthesia care unit (PACU). Rescue analgesia was administered when the visual analogue scale (VAS) score was ≥4. Drug selection and dosing were determined by the anesthesiologist responsible for PACU care. The outcome was recorded as yes/no and summarized as the number and percentage of patients receiving rescue analgesia.

Within the first 45 minutes after arrival in the post-anesthesia care unit.
Postoperative Length of Hospital Stay
時間枠:From the date of surgery until hospital discharge, assessed up to 15 days after surgery.

Postoperative length of hospital stay was defined as the duration from the day of breast cancer surgery to hospital discharge, measured in days.

From the date of surgery until hospital discharge, assessed up to 15 days after surgery.

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2026年4月17日

一次修了 (実際)

2026年8月20日

研究の完了 (実際)

2026年8月30日

試験登録日

最初に提出

2026年4月17日

QC基準を満たした最初の提出物

2026年4月17日

最初の投稿 (実際)

2026年4月23日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月17日

QC基準を満たした最後の更新が送信されました

2026年11月16日

最終確認日

2026年11月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • 2026-04/76

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

IPD プランの説明

Individual participant data (IPD) will not be shared. The study involves sensitive clinical data collected from patients in a single-center setting, and data sharing is restricted in order to protect patient confidentiality and comply with institutional and ethical regulations.

De-identified and aggregated data may be available from the corresponding author upon reasonable request, subject to approval by the institutional ethics committee.

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。